The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 10, 2026

Filed:

Jun. 17, 2021
Applicant:

Pfizer Inc., New York, NY (US);

Inventors:

Annaliesa Sybil Anderson, Upper Saddle River, NJ (US);

Alexey Vyacheslavovitch Gribenko, New City, NY (US);

William Carl Gruber, Warwick, NY (US);

Kathrin Ute Jansen, New York, NY (US);

Lakshmi Khandke, Nanuet, NY (US);

Nicholas Randolph Everard Kitchin, Sandwich, GB;

Jody Lawrence, Lansdale, PA (US);

Yahong Peng, Ambler, PA (US);

Michael William Pride, Staten Island, NY (US);

Christopher Frederick Webber, Sandwich, GB;

Sabine Susanne Wellnitz, Nanuet, NY (US);

Zhuobiao Yi, Berwyn, PA (US);

Assignee:

Pfizer Inc., New York, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/08 (2006.01); A61K 9/19 (2006.01); A61K 39/00 (2006.01); A61K 47/26 (2006.01); A61P 31/04 (2006.01); C07K 16/12 (2006.01); C07K 16/1282 (2026.01);
U.S. Cl.
CPC ...
A61K 39/08 (2013.01); A61K 9/19 (2013.01); A61K 47/26 (2013.01); A61P 31/04 (2018.01); C07K 16/1282 (2013.01); A61K 2039/55577 (2013.01); A61K 2039/575 (2013.01);
Abstract

In one aspect, the invention relates to an immunogenic composition that includes atoxoid A and/or atoxoid B, and methods of use thereof. In another aspect, the invention relates to a method for eliciting an immune response in a human against ainfection. The method includes administering to the human an effective dose of a composition, which includes atoxoid, wherein the composition is administered at least two times, and wherein the immune response againsttoxin A and/or toxin B is sustained.


Find Patent Forward Citations

Loading…